Pharmacological Management of Secondary Hyperparathyroidism in Dialysis Patients: A Narrative Review of Calcimimetics, Vitamin D Analogs, and Phosphate Binders. [PDF]
CureusAlwashahi H, Unnikrishnan Meenakshi D.
europepmc +1 more source
Treatment Satisfaction with Tenapanor: Real-World Survey of Patients with End-Stage Renal Disease and Hyperphosphatemia. [PDF]
Patient Prefer AdherenceKendrick JB +3 more
europepmc +1 more source
Correction to: Tenapanor as Therapy for Hyperphosphatemia in Maintenance Dialysis Patients: Results from the OPTIMIZE Study. [PDF]
Kidney360Sprague SM +14 more
europepmc +1 more source
Patient characteristics associated with the need for high doses of tenapanor hydrochloride in dialysis patients with hyperphosphatemia: A pooled analysis of three clinical trials. [PDF]
PLoS OneNagano N +4 more
europepmc +1 more source
Calciphylaxis as a Rare Complication Associated with Pemigatinib Treatment-A Case Report. [PDF]
Curr OncolČular K +7 more
europepmc +1 more source
The effects of elevated phosphate on the kidney - damaging the gatekeeper. [PDF]
Pflugers ArchMitchell T, Verma V, Fajol A, Faul C.
europepmc +1 more source
Case Report: Three pathogenic molecular findings in a patient with myotonia congenita, pseudohypoparathyroidism, and a glaucoma-suspect phenotype. [PDF]
Front Endocrinol (Lausanne)Mukhtar NN +5 more
europepmc +1 more source
Phosphate-latest news and ongoing trials. [PDF]
Clin Kidney JParpia AS +6 more
europepmc +1 more source